Method for controlling angiogenesis in animals
US6890906B2 · kind B2 · utility
13Cited by
8References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2002 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Nov 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disease conditions which are dependent upon or moderated by angiogenesis are controlled by the use of a therapeutic material which interacts with cell surface galectins. Particular therapeutic materials comprise a polymeric backbone having side chains terminating in a sugar dependent therefrom. Disclosed are specific therapeutic materials in which the polymeric backbone is based upon polygalacturonic acid, and the side chains terminate in arabinose or galactose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.